article thumbnail

LB-102 for the Treatment of Acutely Exacerbated Schizophrenia: Insights From the Principal Investigator

Psychiatric Times

In this exclusive interview with Psychiatric Times, John Kane, MD, shares more on the new positive data on LB-102 for the treatment of acutely exacerbated schizophrenia.